Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
19.95
-0.61 (-2.97%)
May 12, 2026, 3:00 PM CST
SHA:688687 Revenue
Beijing Kawin Technology Share-Holding had revenue of 206.89M CNY in the quarter ending March 31, 2026, a decrease of -10.67%. This brings the company's revenue in the last twelve months to 1.30B, up 3.75% year-over-year. In the year 2025, Beijing Kawin Technology Share-Holding had annual revenue of 1.32B with 7.35% growth.
Revenue (ttm)
1.30B
Revenue Growth
+3.75%
P/S Ratio
2.66
Revenue / Employee
2.16M
Employees
600
Market Cap
3.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.32B | 90.49M | 7.35% |
| Dec 31, 2024 | 1.23B | -181.71M | -12.87% |
| Dec 31, 2023 | 1.41B | 252.03M | 21.73% |
| Dec 31, 2022 | 1.16B | 15.62M | 1.36% |
| Dec 31, 2021 | 1.14B | 282.30M | 32.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qingdao Vland Biotech INC. | 1.40B |
| Guangdong VTR Bio-Tech | 842.50M |
| Hubei Goto Biopharm | 628.90M |
| Zhejiang Shouxiangu Pharmaceutical | 625.30M |
| Shanghai Model Organisms Center | 432.55M |
| Guanhao Biotech | 386.40M |
| Jiangsu Sihuan Bioengineering | 381.71M |
| Yantai Zhenghai Biotechnology | 347.75M |